Cleared Traditional

RealNow (K213891) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K213891 · Yiwei Medical Technology Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
437d
Days
Class 2
Risk

K213891 is an FDA 510(k) clearance for the RealNow. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Yiwei Medical Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on February 24, 2023 after a review of 437 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Yiwei Medical Technology Co., Ltd. devices

Submission Details

510(k) Number K213891 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 14, 2021
Decision Date February 24, 2023
Days to Decision 437 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
330d slower than avg
Panel avg: 107d · This submission: 437d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Mid-Link Consulting Co, Ltd.
Diana Hong

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 819
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K213891.
CoverScan (CoverScan v1.1)
K230294 · Perspectum · Mar 2023
Xeleris V Processing and Review System
K221680 · Ge Healthcare · Mar 2023
Advantis Platform
K222975 · Advantis Medical Imaging Single Member P.C. · Mar 2023
Clarus Viewer
K222757 · Clarus Viewer Corporation · Feb 2023
EzDent-i / E2 / Prora View/ Smart M Viewer
K223820 · Ewoosoft Co., Ltd. · Feb 2023
syngo.via View&GO VA40A
K230196 · Siemens Healthcare GmbH · Feb 2023